Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

Description

Alpha-1 antitrypsin deficiency associated (AATD) is a leading genetic cause of liver disease, yet it remains largely underdiagnosed and poorly understood. This interactive symposium features a multispecialty expert panel to provide insights into the pathophysiologic and genetic underpinnings, best practices in diagnosing, and navigating the management of AATD liver disease.  

Supported by: An educational grant from Takeda Development Center Americas, Inc. 

Organizer: Clinical Care Options (CCO)

For more information and to register, visit:  https://clinicaloptions.com/events/alpha-1-antitrypsin-deficiency-liver-disease/12491 

Objectives

  • Identify clinical manifestations of AATD-LD
  • Position recommended diagnostic procedures for suspected AATD-LD
  • Implement noninvasive tests to assess liver fibrosis in patients with AATD-LD
  • Summarize investigational therapeutic approaches for AATD-LD